Here are five observations:
1. The shift to outpatient spine surgery serves as the ultimate boost for the spinal implants market.
2. The increasing number of non-fusion spinal procedures will also spur market growth.
3. With the growing popularity of non-fusion procedures, many companies have started developing devices for artificial disc replacement, dynamic stabilization and interspinous process decompression.
4. Spinal implant-associated complications could hinder market growth.
5. DePuy Synthes, Medtronic, NuVasive, Stryker and Zimmer Biomet lead the market.
More articles on devices:
St. Mary’s Medical Center surgeons complete 100th Mazor robotic spine surgery: 3 highlights
Avitus Orthopaedics launches Avitus Bone Harvester — 5 highlights
Top 5 vendors in global sports medicine market: Stryker, DePuy Synthes & more
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
